Mosafdin Tablet (Mosapride Citrate Hydrate)

Adult dose

Adults: Administer 15 mg of mosapride citrate anhydrous orally in 3 divided doses daily, before or after meals.

During the use of this medication, diarrhea or loose stools, dry mouth, and malaise may be experienced. If symptoms of hepatitis or jaundice occur, discontinue use immediately and consult a doctor, as liver function may be impaired. Allergic reactions such as rash or urticaria may occur, so caution is required if skin anomalies develop. Gastrointestinal symptoms may include abdominal distension, oral and tongue numbness, nausea, and vomiting. In blood tests, eosinophilia or elevated liver enzymes has been reported, and symptoms of increased heart rate may also be present. Neurological symptoms such as dizziness or headaches may rarely occur, so it is important to monitor your condition closely. This medication contains lactose, so patients with lactose intolerance or certain genetic conditions should not take it. If symptoms do not improve after taking for more than 2 weeks, it is advisable not to continue long-term use. When taken with anticholinergics, the effect of this medication may be diminished, so care should be taken to space out the doses. Women who are pregnant or may become pregnant should only take it after consulting a doctor, and during breastfeeding, it is best to avoid taking it or to discontinue breastfeeding. Safety in children has not been established; therefore, its use is not recommended. Elderly patients should be cautious when taking it, as kidney and liver function may decline, and adjustments in dosage should be made if adverse reactions occur. Keep out of reach of children, and avoid transferring the medication to another container. In animal studies, the risk of tumor development has been reported with high-dose long-term administration, so caution is needed with prolonged use.

• Diarrhea
• loose stools
• dry mouth
• fatigue
• eosinophilia
• increase in triglycerides
• increase in AST
• increase in ALT
• increase in ALP
• increase in γ-GTP

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain its effectiveness over time.

Appearance

White oblong film-coated tablet with a break line

Package unit

30 tablets/bottle, 600 tablets/bottle